Class Actions Over Vytorin Marketing Certified by Judge

, New Jersey Law Journal


A federal judge on September 25 certified as class actions a pair of suits claiming Merck & Co. and former Schering-Plough Corp. withheld information about the effectiveness of the anti-cholesterol drug Vytorin.

This premium content is reserved for The Legal Intelligencer subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1349000152631

Thank you!

This article's comments will be reviewed.